Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations.

[1]  C. Autore,et al.  Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis , 2022, European journal of heart failure.

[2]  U. Eriksson,et al.  Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. , 2021, European heart journal.

[3]  P. Elliott,et al.  Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT. , 2020, JACC. Heart failure.

[4]  Mohamed Kazamel,et al.  Hereditary Transthyretin Amyloidosis: Clinical Presentation and Management Updates. , 2020, Journal of clinical neuromuscular disease.

[5]  C. Di Mario,et al.  Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis. , 2020, Circulation. Heart failure.

[6]  C. Autore,et al.  Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. , 2019, JACC. Cardiovascular imaging.

[7]  M. Maurer,et al.  Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[8]  C. Rapezzi,et al.  Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS) , 2019, European heart journal.

[9]  S. Solomon,et al.  Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study , 2019, Circulation.

[10]  A. Petrie,et al.  A new staging system for cardiac transthyretin amyloidosis , 2018, European heart journal.

[11]  James C Moon,et al.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis , 2016, Circulation.

[12]  C. Rapezzi,et al.  Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy , 2016, Open Heart.

[13]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[14]  P. Cosnay,et al.  Cardiac amyloidosis: updates in diagnosis and management. , 2013, Archives of cardiovascular diseases.

[15]  H. Jono,et al.  Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  C. Rapezzi,et al.  Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis , 2013, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[17]  G. Merlini,et al.  Diagnostic and Prognostic Value of Low QRS Voltages in Cardiac AL Amyloidosis , 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[18]  Q. Fang,et al.  The Findings of Electrocardiography in Patients with Cardiac Amyloidosis , 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[19]  C. Rapezzi,et al.  Cardiac involvement in hereditary-transthyretin related amyloidosis , 2012, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[20]  V. Planté-Bordeneuve,et al.  Familial amyloid polyneuropathy , 2011, The Lancet Neurology.

[21]  F. Salvi,et al.  Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types , 2009, Circulation.

[22]  M. Skinner,et al.  Binding of serum amyloid P-component (SAP) by amyloid fibrils. , 1979, Clinical and experimental immunology.

[23]  N. Yamada,et al.  Annual electrocardiograms consistent with silent progression of cardiac involvement in sporadic familial amyloid polyneuropathy: a case report. , 2010, Internal medicine.